These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10881591)

  • 1. Magnetic resonance imaging of brain lesions of a patient with hemolytic uremic syndrome following Escherichia coli O157 infection.
    Yasuhara A; Araki A; Ochi A; Kobayashi Y
    Pediatr Int; 2000 Jun; 42(3):302-5. PubMed ID: 10881591
    [No Abstract]   [Full Text] [Related]  

  • 2. Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7.
    Gransden WR; Damm MA; Anderson JD; Carter JE; Lior H
    J Infect Dis; 1986 Sep; 154(3):522-4. PubMed ID: 3525698
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
    Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
    FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foodborne diseases: Shiga toxin producing E. coli (STEC).
    Bower JR
    Pediatr Infect Dis J; 1999 Oct; 18(10):909-10. PubMed ID: 10530589
    [No Abstract]   [Full Text] [Related]  

  • 5. Escherichia coli O157 in Somerset.
    Commun Dis Rep CDR Wkly; 1998 May; 8(19):167. PubMed ID: 9635338
    [No Abstract]   [Full Text] [Related]  

  • 6. [E.coli O157 infection].
    Igarashi T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):20-3. PubMed ID: 10088327
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.
    Mahon BE; Griffin PM; Mead PS; Tauxe RV
    Emerg Infect Dis; 1997; 3(3):409-12. PubMed ID: 9284395
    [No Abstract]   [Full Text] [Related]  

  • 8. Bacterial genotype and neurological complications of Escherichia coli O157:H7-associated haemolytic uraemic syndrome.
    Cimolai N; Carter JE
    Acta Paediatr; 1998 May; 87(5):593-4. PubMed ID: 9641746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enterohemorrhagic Escherichia coli--infection and a hemolytic uremic syndrome].
    Helminen M; Wisakanto KL; Raisio M; Baer M
    Duodecim; 1998; 114(3):229-32. PubMed ID: 10895492
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome.
    Kawamura N; Yamazaki T; Tamai H
    Pediatr Int; 1999 Apr; 41(2):218-22. PubMed ID: 10221033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome.
    Raffaelli RM; Paladini M; Hanson H; Kornstein L; Agasan A; Slavinski S; Weiss D; Fennelly GJ; Flynn JT
    Pediatr Infect Dis J; 2007 Oct; 26(10):951-3. PubMed ID: 17901803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature.
    Ko H; Maymani H; Rojas-Hernandez C
    J Med Case Rep; 2016 Jun; 10():175. PubMed ID: 27301547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The shiga-like toxin-producing Escherichia coli and hemolytic uremic syndrome.
    Cleary TG; Lopez EL
    Pediatr Infect Dis J; 1989 Oct; 8(10):720-4. PubMed ID: 2682505
    [No Abstract]   [Full Text] [Related]  

  • 14. Verocytotoxigenic Escherichia coli serologic responses in patients with hemolytic uremic syndrome.
    Goldwater PN; Bettelheim KA
    J Infect Dis; 2002 Aug; 186(4):582; author reply 582-3. PubMed ID: 12195391
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.
    Lopez EL; Diaz M; Grinstein S; Devoto S; Mendilaharzu F; Murray BE; Ashkenazi S; Rubeglio E; Woloj M; Vasquez M
    J Infect Dis; 1989 Sep; 160(3):469-75. PubMed ID: 2668430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, pathogenesis and therapeutic modalities in hemolytic-uremic syndrome.
    Zimmerhackl LB
    Kidney Blood Press Res; 1998; 21(2-4):290-2. PubMed ID: 9762861
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolytic uremic syndrome: an emerging health risk.
    Razzaq S
    Am Fam Physician; 2006 Sep; 74(6):991-6. PubMed ID: 17002034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
    Johnson KE; Thorpe CM; Sears CL
    Clin Infect Dis; 2006 Dec; 43(12):1587-95. PubMed ID: 17109294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of Escherichia coli O157 in a soil protozoan: implications for disease.
    Barker J; Humphrey TJ; Brown MW
    FEMS Microbiol Lett; 1999 Apr; 173(2):291-5. PubMed ID: 10227158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.